1. Home
  2. AILEW vs IDYA Comparison

AILEW vs IDYA Comparison

Compare AILEW & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AILEW
  • IDYA
  • Stock Information
  • Founded
  • AILEW N/A
  • IDYA 2015
  • Country
  • AILEW United States
  • IDYA United States
  • Employees
  • AILEW N/A
  • IDYA N/A
  • Industry
  • AILEW Blank Checks
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AILEW Finance
  • IDYA Health Care
  • Exchange
  • AILEW Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • AILEW N/A
  • IDYA 2.2B
  • IPO Year
  • AILEW 2021
  • IDYA 2019
  • Fundamental
  • Price
  • AILEW $0.06
  • IDYA $26.23
  • Analyst Decision
  • AILEW
  • IDYA Strong Buy
  • Analyst Count
  • AILEW 0
  • IDYA 12
  • Target Price
  • AILEW N/A
  • IDYA $53.67
  • AVG Volume (30 Days)
  • AILEW N/A
  • IDYA 1.1M
  • Earning Date
  • AILEW N/A
  • IDYA 11-04-2024
  • Dividend Yield
  • AILEW N/A
  • IDYA N/A
  • EPS Growth
  • AILEW N/A
  • IDYA N/A
  • EPS
  • AILEW N/A
  • IDYA N/A
  • Revenue
  • AILEW N/A
  • IDYA $3,922,000.00
  • Revenue This Year
  • AILEW N/A
  • IDYA N/A
  • Revenue Next Year
  • AILEW N/A
  • IDYA $251.89
  • P/E Ratio
  • AILEW N/A
  • IDYA N/A
  • Revenue Growth
  • AILEW N/A
  • IDYA N/A
  • 52 Week Low
  • AILEW N/A
  • IDYA $24.48
  • 52 Week High
  • AILEW N/A
  • IDYA $47.74
  • Technical
  • Relative Strength Index (RSI)
  • AILEW N/A
  • IDYA 37.58
  • Support Level
  • AILEW N/A
  • IDYA $24.48
  • Resistance Level
  • AILEW N/A
  • IDYA $27.15
  • Average True Range (ATR)
  • AILEW 0.00
  • IDYA 1.34
  • MACD
  • AILEW 0.00
  • IDYA -0.11
  • Stochastic Oscillator
  • AILEW 0.00
  • IDYA 7.90

About AILEW iLearningEngines Inc. Warrant

iLearningEngines Inc is an AI and automation platform that empowers its customers to productize their institutional knowledge by transforming it into actionable intellectual property that enhances outcomes for employees, customers and other stakeholders. Its platform enables enterprises to build intelligent Knowledge Clouds that incorporate large volumes of structured and unstructured information across disparate internal and external systems and to automate organizational processes that leverage these Knowledge Clouds to improve performance. The company combines its offerings with vertically focused capabilities and data models to operationalize AI and automation to effectively and efficiently address critical challenges facing its customers.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

Share on Social Networks: